Responding to potentially disruptive technologies: Why do incumbent pharmaceutical companies acquire biotechnological companies and how have these motives changed over time

Responding to potentially disruptive technologies: Why do incumbent pharmaceutical companies acquire biotechnological companies and how have these motives changed over time

Bibliographic Details
Main Author: Jähnig, Lukas (-)
Corporate Author: ESADE. Escola Superior d'Administració i Direcció d'Empreses (-)
Other Authors: Visnjic, Ivanka, dir (Conductor)
Format: Thesis
Language:Inglés
Published: 2017
Subjects:
Indústria farmacèutica
Biotecnologia
Master Thesis
Tesis i dissertacions electròniques
Treballs de fi d'estudis
Online Access:Accés restringit als usuaris d'ESADE
See on Biblioteca Universitat Ramon Llull:https://discovery.url.edu/permalink/34CSUC_URL/1im36ta/alma991007232519706719
Description
Item Description:Master in Finance
Physical Description:1 recurs electrònic ( 60 p.)

Similar Items